DK1355668T3 - Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom - Google Patents

Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom

Info

Publication number: DK1355668T3
Authority: DK; Denmark
Prior art keywords: inhibitors; prevention; treatment; heart disease; heart
Prior art date: 2001-01-29

Application number

DK02718052T

Other languages

Danish (da)

English (en)

Inventor

Benjamin Pomerantz

Charles Dinarello

Leonid Reznikov

Alden Harken

Yolande Chvatchko

Original Assignee

Serono Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-29

Filing date

2002-01-28

Publication date

2008-05-05

2002-01-28 Application filed by Serono Lab filed Critical Serono Lab

2008-05-05 Application granted granted Critical

2008-05-05 Publication of DK1355668T3 publication Critical patent/DK1355668T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cell Biology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK02718052T 2001-01-29 2002-01-28 Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom DK1355668T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01101959		2001-01-29
PCT/EP2002/000844 WO2002060479A1 (en)	2001-01-29	2002-01-28	Use of il-18 inhibitors for the treatment and/or prevention of heart disease

Publications (1)

Publication Number	Publication Date
DK1355668T3 true DK1355668T3 (da)	2008-05-05

Family

ID=8176323

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02718052T DK1355668T3 (da)	2001-01-29	2002-01-28	Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom

Country Status (31)

Country	Link
US (1)	US20040234523A1 (et)
EP (1)	EP1355668B1 (et)
JP (2)	JP4860897B2 (et)
KR (1)	KR100857376B1 (et)
CN (1)	CN1326562C (et)
AR (1)	AR032422A1 (et)
AT (1)	ATE380558T1 (et)
BG (1)	BG66483B1 (et)
BR (1)	BR0206819A (et)
CA (1)	CA2435466C (et)
CY (1)	CY1107203T1 (et)
CZ (1)	CZ305653B6 (et)
DE (1)	DE60224004T2 (et)
DK (1)	DK1355668T3 (et)
EA (2)	EA010180B1 (et)
EE (1)	EE05534B1 (et)
ES (1)	ES2295332T3 (et)
HR (1)	HRP20030609A2 (et)
HU (1)	HU229164B1 (et)
IL (2)	IL157024A0 (et)
ME (1)	ME00549B (et)
MX (1)	MXPA03006776A (et)
NO (1)	NO331083B1 (et)
PL (1)	PL213568B1 (et)
PT (1)	PT1355668E (et)
RS (1)	RS51125B (et)
SI (1)	SI1355668T1 (et)
SK (1)	SK287620B6 (et)
UA (1)	UA80676C2 (et)
WO (1)	WO2002060479A1 (et)
ZA (1)	ZA200305439B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20120011898A (ko)	2000-02-10	2012-02-08	아보트 러보러터리즈	사람 인터류킨-１８에 결합하는 항체 및 이를 제조하고 사용하는 방법
CA2424983A1 (en)	2000-10-11	2002-04-18	Viron Therapeutics, Inc.	Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en)	2000-12-04	2010-05-18	Viron Therapeutics Inc.	Immunomodulatory protein and useful embodiments thereof
AU2004238524B2 (en)	2003-05-13	2011-06-23	Merck Serono Sa	Active variants of the IL-18 binding protein and medical uses thereof
US7968684B2 (en) *	2003-11-12	2011-06-28	Abbott Laboratories	IL-18 binding proteins
JP4961559B2 (ja) *	2004-03-11	2012-06-27	友昭星野	インターロイキン１８阻害剤を有効成分とする疾患の予防又は治療剤
DK1885753T3 (da)	2005-06-03	2011-10-03	Ares Trading Sa	Fremstilling af rekombinant II-18-proteiner
HRP20110948T1 (hr)	2005-06-10	2012-01-31	Ares Trading S.A.	Postupak za pročišćavanje il-18 vezujućeg proteina
EP2207475A4 (en)	2007-11-05	2010-12-22	Kci Licensing Inc	IDENTIFICATION OF TISSUE FOR DEBRIDEMENT
JOP20200308A1 (ar)	2012-09-07	2017-06-16	Novartis Ag	جزيئات إرتباط il-18
PL3041864T3 (pl) *	2013-09-05	2021-12-20	Ab2 Bio Sa	Białko wiążące il-18 (il-18bp) w chorobach zapalnych
CA2972689A1 (en)	2015-03-05	2016-09-09	Ab2 Bio Sa	Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases
WO2018013509A1 (en) *	2016-07-11	2018-01-18	Arizona Board Of Regents On Behalf Of The University Of Arizona	Compositions and methods for diagnosing and treating arrhythmias

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6204261B1 (en) *	1995-12-20	2001-03-20	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β Converting enzyme inhibitors
US5605690A (en) *	1989-09-05	1997-02-25	Immunex Corporation	Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
NZ322197A (en) *	1995-11-21	1999-02-25	Yamanouchi Pharma Co Ltd	Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
ES2255112T3 (es) *	1996-09-12	2006-06-16	Idun Pharmaceuticals, Inc.	Inhibicion de apoptosis usando inhibidores de la familia de la enzima convertidora de interleucina 1-beta (ice)/ced-3.
ATE346085T1 (de) *	1996-12-06	2006-12-15	Vertex Pharma	Inhibitoren des interleukin-1-beta konvertierenden enzyms
TR199902615T2 (xx) *	1997-03-18	2000-03-21	Basf Aktiengesellschaft	Kortikosteroidlere verilen cevab�n mod�lasyonuna y�nelik metodlar ve kompozisyonlar.
IL121860A0 (en) *	1997-08-14	1998-02-22	Yeda Res & Dev	Interleukin-18 binding proteins their preparation and use
DE19743687C1 (de) *	1997-10-06	1998-11-26	Henkel Kgaa	Detergensgemische und deren Verwendung
WO2000000490A2 (en) *	1998-06-26	2000-01-06	Eli Lilly And Company	5-ht1f agonists
WO2000012555A1 (en) *	1998-09-01	2000-03-09	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Interleukin 18-binding protein
EP1022027A1 (en) *	1999-01-22	2000-07-26	Applied Research Systems ARS Holding N.V.	Tumor necrosis factor antagonists and their use in endometriosis
DE60030097T2 (de) *	1999-03-16	2007-03-08	Cytovia, Inc., San Diego	Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung
KR20020005665A (ko) *	1999-04-09	2002-01-17	추후보정	카스파제 저해제 및 그것의 용도
WO2001003719A2 (en) *	1999-07-09	2001-01-18	Amgen Inc.	Combination therapy for conditions leading to bone loss
KR20120011898A (ko) *	2000-02-10	2012-02-08	아보트 러보러터리즈	사람 인터류킨-１８에 결합하는 항체 및 이를 제조하고 사용하는 방법
UA78492C2 (en) *	2000-05-05	2007-04-10	Applied Research Systems	Use of il-18 inhibitor for treatment and/or prevention of atherosclerosis
AU2002224417A1 (en) *	2000-10-18	2002-04-29	Immunex Corporation	Methods for treating il-18 mediated disorders

2002
- 2002-01-28 EA EA200501549A patent/EA010180B1/ru not_active IP Right Cessation
- 2002-01-28 SI SI200230667T patent/SI1355668T1/sl unknown
- 2002-01-28 ZA ZA200305439A patent/ZA200305439B/en unknown
- 2002-01-28 DE DE60224004T patent/DE60224004T2/de not_active Expired - Lifetime
- 2002-01-28 CZ CZ2003-2335A patent/CZ305653B6/cs not_active IP Right Cessation
- 2002-01-28 ES ES02718052T patent/ES2295332T3/es not_active Expired - Lifetime
- 2002-01-28 CA CA2435466A patent/CA2435466C/en not_active Expired - Lifetime
- 2002-01-28 US US10/470,303 patent/US20040234523A1/en not_active Abandoned
- 2002-01-28 WO PCT/EP2002/000844 patent/WO2002060479A1/en not_active Ceased
- 2002-01-28 CN CNB02807503XA patent/CN1326562C/zh not_active Expired - Lifetime
- 2002-01-28 JP JP2002560670A patent/JP4860897B2/ja not_active Expired - Lifetime
- 2002-01-28 UA UA2003088056A patent/UA80676C2/uk unknown
- 2002-01-28 PT PT02718052T patent/PT1355668E/pt unknown
- 2002-01-28 DK DK02718052T patent/DK1355668T3/da active
- 2002-01-28 PL PL366802A patent/PL213568B1/pl unknown
- 2002-01-28 MX MXPA03006776A patent/MXPA03006776A/es active IP Right Grant
- 2002-01-28 RS YUP-578/03A patent/RS51125B/sr unknown
- 2002-01-28 ME MEP-2008-681A patent/ME00549B/me unknown
- 2002-01-28 AT AT02718052T patent/ATE380558T1/de active
- 2002-01-28 EP EP02718052A patent/EP1355668B1/en not_active Expired - Lifetime
- 2002-01-28 HU HU0303306A patent/HU229164B1/hu unknown
- 2002-01-28 EE EEP200300328A patent/EE05534B1/et unknown
- 2002-01-28 IL IL15702402A patent/IL157024A0/xx unknown
- 2002-01-28 SK SK1089-2003A patent/SK287620B6/sk not_active IP Right Cessation
- 2002-01-28 KR KR1020037009941A patent/KR100857376B1/ko not_active Expired - Lifetime
- 2002-01-28 EA EA200300844A patent/EA006767B1/ru not_active IP Right Cessation
- 2002-01-28 BR BR0206819-2A patent/BR0206819A/pt not_active Application Discontinuation
- 2002-01-28 HR HR20030609A patent/HRP20030609A2/xx not_active Application Discontinuation
- 2002-01-29 AR ARP020100315A patent/AR032422A1/es unknown
2003
- 2003-07-16 NO NO20033228A patent/NO331083B1/no not_active IP Right Cessation
- 2003-07-20 IL IL157024A patent/IL157024A/en active IP Right Grant
- 2003-08-25 BG BG108128A patent/BG66483B1/bg unknown
2008
- 2008-02-18 CY CY20081100195T patent/CY1107203T1/el unknown
- 2008-12-16 JP JP2008319532A patent/JP2009102354A/ja active Pending

Also Published As

Publication number	Publication date
UA80676C2 (en)	2007-10-25
EE05534B1 (et)	2012-04-16
CA2435466C (en)	2012-04-03
HUP0303306A3 (en)	2005-12-28
HUP0303306A2 (hu)	2004-01-28
ATE380558T1 (de)	2007-12-15
IL157024A (en)	2014-02-27
EA200300844A1 (ru)	2003-12-25
YU57803A (sh)	2006-05-25
CN1499982A (zh)	2004-05-26
JP4860897B2 (ja)	2012-01-25
AR032422A1 (es)	2003-11-05
ES2295332T3 (es)	2008-04-16
JP2009102354A (ja)	2009-05-14
NO331083B1 (no)	2011-10-03
EA006767B1 (ru)	2006-04-28
PL366802A1 (en)	2005-02-07
CA2435466A1 (en)	2002-08-08
BG108128A (bg)	2004-11-30
ME00549B (me)	2011-10-10
EA010180B1 (ru)	2008-06-30
CY1107203T1 (el)	2012-11-21
US20040234523A1 (en)	2004-11-25
EP1355668B1 (en)	2007-12-12
EE200300328A (et)	2003-10-15
JP2004522748A (ja)	2004-07-29
ZA200305439B (en)	2004-07-15
KR100857376B1 (ko)	2008-09-05
SI1355668T1 (sl)	2008-06-30
HK1062810A1 (en)	2004-11-26
BG66483B1 (bg)	2015-03-31
BR0206819A (pt)	2004-02-03
PT1355668E (pt)	2008-01-04
CZ20032335A3 (en)	2004-07-14
HU229164B1 (en)	2013-09-30
CZ305653B6 (cs)	2016-01-27
PL213568B1 (pl)	2013-03-29
IL157024A0 (en)	2004-02-08
NO20033228L (no)	2003-09-26
DE60224004D1 (de)	2008-01-24
MXPA03006776A (es)	2003-10-24
HRP20030609A2 (en)	2005-06-30
EP1355668A1 (en)	2003-10-29
KR20030070143A (ko)	2003-08-27
SK287620B6 (sk)	2011-04-05
EA200501549A1 (ru)	2006-04-28
WO2002060479A1 (en)	2002-08-08
DE60224004T2 (de)	2009-07-23
SK10892003A3 (sk)	2004-02-03
RS51125B (sr)	2010-10-31
CN1326562C (zh)	2007-07-18
NO20033228D0 (no)	2003-07-16

Publication	Publication Date	Title
DK1487541T3 (da)	2009-01-19	Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
DK1663978T3 (da)	2008-04-07	Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20044195L (no)	2004-10-01	Biofosfoninsyrer for behandling og prevensjon av osteoprose
IL245955B (en)	2018-01-31	Immunogenic compositions for the prevention and treatment of meningococcal disease
DK1539224T3 (da)	2008-03-31	Antimikrobielt præparat og fremgangsmåde til anvendelse
NO20044272L (no)	2004-12-15	Legemiddel for behandling og/eller forebyggelse av kronisk avstotning
IS7189A (is)	2004-03-19	Sómatóstatín- eða bombesínhliðstæðusamstæður til greiningar eða meðferðar og notkun þeirra
NO20041872L (no)	2004-05-06	Esterforbindelser og medisinsk anvendelse derav
NO20041216L (no)	2004-05-05	Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
DK1427437T3 (da)	2013-03-04	Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1446122T5 (da)	2006-08-14	Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
DK1765388T3 (da)	2013-07-22	Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil
NO20043370L (no)	2004-09-28	N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20033854L (no)	2003-10-28	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20050569D0 (no)	2005-02-02	Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
DK1278540T3 (da)	2008-07-21	Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
NO20041214L (no)	2004-06-24	Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
NO20031806D0 (no)	2003-04-23	Anvendelse av pericytt apoptosehemmere for behandling og/eller forhindringav diabetisk retinopati
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1355668T3 (da)	2008-05-05	Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20033506L (no)	2003-10-08	Parasitticidale preparater og metoder for anvendelse
ITTO20010848A0 (it)	2001-09-05	Disposizione e metodo di purificazione o trattamento elettrochimico.
NO20054913D0 (no)	2005-10-24	Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
DE60222664D1 (de)	2007-11-08	Hautbehandlungsmittel